Glucose Health Inc. in brief
Glucose Health Inc. is a listed company in the Package Foods industry, based in Bentonville, Arkansas, USA. Its last known market value was $1 M (December 2022); there is no current figure. In the year to December 2016 it had sales of $0 M and a net loss of $0 M.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Glucose Health Inc. timeline
- 2007
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2014
- ✎Renamed Glucose Health, Inc.Formerly Bio-Solutions Corp..
Events of Glucose Health Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #5,725 (Jan 2022) · #5,911 (Dec 2022)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin (TTM)
- -132.3%
- Operating margin
- -29.0%
- Return on equity
- —
- Liabilities / assets
- 1766.7%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2016 | $0M | — | $-0M | $-0M | -132.3% |
| Dec 2015 | — | — | $-0M | $-0M | — |
| Dec 2014 | — | — | $-1M | $-1M | — |
| Dec 2013 | — | — | $-1M | $-1M | — |
| Dec 2012 | — | — | $-0M | $-0M | — |
| Dec 2011 | — | — | $-1M | $-1M | — |
| Dec 2010 | — | — | $-1M | $-1M | — |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2016 | $-0M | — | — | — | — |
| Dec 2015 | $-0M | — | — | — | — |
| Dec 2014 | $-0M | — | — | — | — |
| Dec 2013 | $-0M | — | — | — | — |
| Dec 2012 | $-0M | — | — | — | — |
| Dec 2011 | $-0M | — | — | — | — |
| Dec 2010 | $-0M | — | — | — | — |
SEC filings
- Jan 9, 2023S-1/AIPO registration (amended)
- Sep 6, 2022S-1/AIPO registration (amended)
- Aug 5, 2022S-1/AIPO registration (amended)
- Jun 1, 2022S-1IPO registration
- Nov 14, 201710-QQuarterly report · period to Sep 2017
- Aug 21, 201710-QQuarterly report · period to Jun 2017
- May 15, 201710-QQuarterly report · period to Mar 2017
- Apr 11, 20178-KCurrent reportAuditor change
- Mar 29, 201710-KAnnual report · period to Dec 2016
- Dec 21, 201610-QQuarterly report · period to Sep 2016
- Aug 22, 201610-QQuarterly report · period to Jun 2016
- May 23, 201610-QQuarterly report · period to Mar 2016
Official filings of Glucose Health Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $0 M
- Operating income
- $-0 M
- Net income
- $-0 M
For year ending December-2016 · source: SEC filing
Balance sheet
- Total assets
- $0 M
- Total liabilities
- $1 M
- Total equity
- $-1 M
As of December-2016
Glucose Health Inc. scorecard#
Passes 1 of the 6 checks that could be worked out. Fiscal year 2016.
Valuationnot known
- –P/E below its peers' medianNo market cap.
- –Price to book below its peers' medianNo market cap.
- –Price to sales below its peers' medianNo market cap.
- –Free cash flow yield above 5%No market cap.
- –Earnings yield above the 10-year Treasury yieldNo market cap.
- –The price assumes slower growth than the last three years'No market cap.
Growth1 of 1
- –Revenue grew in the newest yearRevenue of the year before is not on file.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
- ✓Net income higher than five years earlier-$0 M-$0 M in fiscal 2016 against -$1 M in 2011.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability0 of 2
- ✗Profitable in the newest year-$0 MNet income -$0 M in fiscal 2016.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2016.
- –Operating margin above its peers' medianNo operating margin on file.
- –Return on equity above 15%No return on equity (equity missing or negative).
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial health0 of 3
- ✗Short-term assets cover short-term liabilities0.1×Current ratio 0.06 at the end of fiscal 2016.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- ✗Operating income covers interest five times-0.3×Operating income -0.3 times interest in fiscal 2016.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2016.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returnsnot known
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- –Share count up no more than 2% in a yearShare counts of two years are not on file.
- –Dividends and buybacks above 3% of the market valueNo market cap.
- –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.
Worked out from the statements as filed (sec), the medians of Package Foods, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Glucose Health Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2016to Dec 31, 2016 | FY 2015to Dec 31, 2015 | FY 2014to Dec 31, 2014 | FY 2013to Dec 31, 2013 | FY 2012to Dec 31, 2012 | FY 2011to Dec 31, 2011 | FY 2010to Dec 31, 2010 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 313+7232%100% | 4.3+56.0%100% | 2.7+1123%100% | 0.2r−0.2—100% | — | — | 2.4—100% | |
| Cost of revenue | 294+7489%93.9% | 3.9+47.0%90.7% | 2.6+13.9%96.2% | 2.3—1033% | — | — | 3.4—139% | |
| Gross profit | 19+4728%6.1% | 0.4—9.3% | −21r−21—−757% | −2.1—−933% | — | — | −0.9—−39.4% | |
| Research and development | — | 0.0−98.8%1.1% | 4.0—146% | — | — | — | — | |
| General and administrative | 52−54.9%16.5% | 115r115+605%2688% | 16r16−58.7%595% | 39+585%17633% | 5.8−60.7%— | 15−63.1%— | 40—1651% | |
| Operating expenses | 106−32.4%33.8% | 157−70.1%3665% | 524r524−58.6%19149% | 1,267+251%565711% | 361−59.3%— | 889+44.8%— | 614—25515% | |
| Operating income | −87—−27.7% | −156—−3656% | −545—−19906% | −1,269—−566645% | −361—— | −889—— | −615—−25555% | |
| Interest expense and finance costs | 324+170%103% | 120+9.5%2810% | 110−35.1%4003% | 169+348%75385% | 38+263%— | 10−42.0%— | 18—744% | |
| Other non-operating income (expense) | −324—−103% | −110—−2572% | −124—−4534% | −190—−84760% | −38—— | −10—— | −18—−744% | |
| Income before tax | −410—−131% | −266—−6228% | −669—−24440% | −1,459—−651404% | −399—— | — | — | |
| Net income including minority interests | — | — | — | −1,459—−651404% | −405—— | — | — | |
| Net income attributable to shareholders | −410—−131% | −266—−6228% | −669—−24440% | −1,459—−651404% | −399—— | −899—— | −633—−26299% | |
| Earnings per share, basic | -0.15—— | -0.14—— | -0.99—— | -4.91r-0.10—— | -0.05r-0.01—— | -0.02—— | -0.03—— | |
| Shares, weighted average (basic) | 2.8+42.8%— | 2.0+190%— | 0.7+127%— | 0.3r15−96.1%— | 7.6r76−79.0%— | 36+98.7%— | 18—— | |
| Balance sheet | ||||||||
| Cash and cash equivalents | 21+900%62.0% | 2.1−57.8%13.3% | 4.9+585%11.1% | 0.7−33.9%2.8% | 1.1+1212%0.5% | 0.1+148%0.0% | 0.0—0.0% | |
| Receivables | 12+272%35.4% | 3.2—20.4% | — | — | — | — | — | |
| Inventory | — | 8.4—54.3% | 0−100%0.0% | 25—97.2% | — | — | 88—100.0% | |
| Current assets | 33+118%99.3% | 15−65.5%98.1% | 44+70.9%99.3% | 26+2278%100% | 1.1−96.0%0.5% | 27−69.2%11.6% | 88—100% | |
| Total assets | 33+115%100% | 15−65.0%100% | 44+72.1%100% | 26−87.7%100% | 208−11.1%100% | 234+166%100% | 88—100% | |
| Accounts payable | 138+45.5%417% | 95−38.6%616% | 155+6.9%351% | 145+17.4%565% | 123−58.4%59.3% | 296−22.9%127% | 385—438% | |
| Debt due within a year | — | — | 170+116%386% | 79—308% | — | — | — | |
| Current liabilities | 529+31.1%1595% | 403+24.2%2617% | 325+45.3%737% | 223+20.4%873% | 185−55.8%89.3% | 420−38.5%180% | 682—777% | |
| Total liabilities | 529+31.1%1595% | 403+24.2%2617% | 325+45.3%737% | 223+20.4%873% | 185−55.8%89.3% | 420−38.5%180% | 682—777% | |
| Retained earnings | −6,248—−18849% | −5,837—−37887% | −5,571—−12653% | −4,902r−2,874—−19155% | −2,874—−1384% | −2,874—−1230% | −2,144—−2443% | |
| Shareholders' equity | −495—−1495% | −388—−2517% | −281—−637% | −198−991%−773% | 22—10.7% | −186—−79.6% | −595r−614—−677% | |
| Total liabilities and equity | 33+115%100% | 15−65.0%100% | 44+72.1%100% | 26−87.7%100% | 208−11.1%100% | 234+166%100% | 88r68—100% | |
| Shares outstanding | 3.3+35.1%— | 2.5+87.2%— | 1.3+247%— | 0.4r19−96.3%— | 10r101−84.6%— | 65+232%— | 20—— | |
| Cash-flow statement | ||||||||
| Share-based compensation | 1.9−94.3%0.6% | 33—767% | — | — | — | — | — | |
| Cash from operating activities | −39—−12.5% | −116—−2710% | −135—−4942% | −132—−58922% | −84—— | −23—— | −110—−4557% | |
| Cash from investing activities | 0.3—0.1% | −0.3—−5.9% | — | — | — | — | — | |
| Shares issued | — | — | — | — | — | 11—— | — | |
| Cash from financing activities | 58−49.2%18.4% | 113−18.9%2650% | 140+6.0%5094% | 132+67.5%58759% | 79+278%— | 21−82.9%— | 121—5043% | |
| Exchange-rate effect on cash | — | — | — | — | 6.1+136%— | 2.6—— | −12—−485% | |
| Change in cash | 18—5.9% | −2.8−168%−65.9% | 4.2—152% | −0.4−137%−163% | 1.0+1929%— | 0.0+69.0%— | 0.0—1.2% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2017 | Q3 FY2017to Sep 30, 2017 | Q2 FY2017to Jun 30, 2017 | Q1 FY2017to Mar 31, 2017 | Q4 FY2016to Dec 31, 2016 | Q3 FY2016to Sep 30, 2016 | Q2 FY2016to Jun 30, 2016 | Q1 FY2016to Mar 31, 2016 | Q4 FY2015to Dec 31, 2015 | Q3 FY2015to Sep 30, 2015 | Q2 FY2015to Jun 30, 2015 | Q1 FY2015to Mar 31, 2015 | Q4 FY2014to Dec 31, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 88−70.6%100% | 24+1027%100% | 34−88.5%100% | 15+12493%100% | 15*+826%100% | 2.1+2.7%100% | 296+53489%100% | 0.1+380%100% | 1.6*—100% | 2.1—100% | 0.6—100% | 0.0—100% | 0*—— | |
| Cost of revenue | 31−89.1%34.6% | 0.8−83.3%3.3% | 0.3−99.9%0.8% | 15+24297%96.9% | 15*+834%97.5% | 4.7+143%224% | 274+80625%92.8% | 0.1—50.0% | 1.6*−85.7%96.6% | 2.0—94.9% | 0.3—61.6% | — | 11r11*—— | |
| Gross profit | 58+206%65.4% | 23—96.7% | 34+58.2%99.2% | 0.5+688%3.1% | 0.4*+602%2.5% | −2.6−2599%−124% | 21+9968%7.2% | 0.1+140%50.0% | 0.1*—3.4% | 0.1—5.1% | 0.2—38.4% | 0.0—100% | −11r−11*—— | |
| General and administrative | 32−74.6%35.8% | 4.7−87.1%19.7% | 7.6+31.0%22.2% | 12+328%82.7% | 6.8*−91.4%44.8% | 36+56.9%1723% | 5.8−36.6%1.9% | 2.9−13.8%2431% | 79r79*+3851%4828% | 23—1127% | 9.1—1647% | 3.4—13540% | 2.0r2.0*—— | |
| Operating expenses | 90−5.7%102% | 18−65.3%77.2% | 18+15.6%52.0% | 29+133%190% | 25*+68.6%166% | 53+54.4%2509% | 15−64.0%5.2% | 12−80.9%10279% | 15*−95.7%913% | 34—1668% | 43—7715% | 65—258972% | 350r350*—— | |
| Operating income | −32—−36.8% | 4.6—19.5% | 16+167%47.2% | −28—−187% | −25*—−164% | −56—−2633% | 6.0—2.0% | −12—−10229% | −15*—−909% | −34—−1663% | −42—−7677% | −65—−258872% | −361*—— | |
| Interest expense and finance costs | 111−53.3%126% | 5.7−94.6%24.1% | 5.1−94.5%15.0% | 0.7−95.9%4.6% | 99*+363%653% | 105+598%4989% | 93+231%31.6% | 17−69.3%14157% | 21*−47.0%1308% | 15—734% | 28—5111% | 55—221112% | 41*—— | |
| Other non-operating income (expense) | −53—−59.7% | 14—59.4% | 33—97.5% | −0.7—−4.6% | −99*—−653% | −105—−4989% | −93—−31.6% | −17—−14157% | −32*—−1944% | −15—−734% | −7.6—−1384% | −55—−221112% | −55*—— | |
| Income before tax | −85—−96.5% | 19—78.9% | 49—145% | −29—−192% | −124*—−817% | −161—−7622% | −87—−29.5% | −29—−24386% | −47*—−2854% | −49—−2397% | −50—−9061% | −120—−479984% | −416*—— | |
| Net income attributable to shareholders | −85—−96.5% | 19—78.9% | 49—145% | −29—−192% | −124*—−817% | −161—−7622% | −87—−29.5% | −29—−24386% | −47*—−2854% | −49—−2397% | −50—−9061% | −120—−479984% | −416*—— | |
| Earnings per share, basic | — | 0.00—— | 0.01—— | -0.01—— | — | -0.06—— | -0.03—— | -0.01—— | — | -0.02—— | -0.03—— | -0.08—— | — | |
| Shares, weighted average (basic) | 4.1+44.2%— | 4.1+44.2%— | 3.7+43.7%— | 3.3+33.5%— | — | 2.9+34.9%— | 2.6+33.7%— | 2.5+60.3%— | — | 2.1—— | 1.9—— | 1.6—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 17—63.1% | 17−29.6%63.1% | 18−34.1%67.0% | 9.0+363%47.7% | 21+900%62.0% | 24+169%53.8% | 28+555%13.4% | 1.9−36.0%3.8% | 2.1−57.8%13.3% | 8.8—41.8% | 4.2—20.6% | 3.0—8.1% | 4.9—11.1% | |
| Receivables | 9.1—34.6% | 9.1−22.5%34.6% | 8.8−94.8%32.2% | 9.6+206%51.1% | 12+272%35.4% | 12+493%26.7% | 168—81.3% | 3.2—6.1% | 3.2—20.4% | 2.0—9.4% | — | — | — | |
| Inventory | 0—0.0% | 0−100%0.0% | 0−100%0.0% | 0−100%0.0% | — | 6.4−33.8%14.6% | 8.3−28.7%4.0% | 8.3−33.5%16.1% | 8.4—54.3% | 9.7—46.1% | 12—56.6% | 13—33.3% | 0—0.0% | |
| Current assets | 26—99.3% | 26−40.1%99.3% | 27−86.9%99.2% | 19−63.7%98.8% | 33+118%99.3% | 44+111%99.3% | 207+920%99.9% | 51+37.7%99.4% | 15−65.5%98.1% | 21—98.6% | 20—98.5% | 37—99.2% | 44—99.3% | |
| Total assets | 26—100% | 26−40.1%100% | 27−86.8%100% | 19−63.5%100% | 33+115%100% | 44+109%100% | 207+906%100% | 52+37.4%100% | 15−65.0%100% | 21—100% | 21—100% | 38—100% | 44—100% | |
| Accounts payable | 78—297% | 78−36.9%297% | 98−42.1%359% | 152+60.4%807% | 138+45.5%417% | 124+30.7%282% | 169+78.1%81.8% | 95−32.0%184% | 95−38.6%616% | 95—452% | 95—462% | 140—371% | 155—351% | |
| Debt due within a year | — | — | — | — | — | — | — | — | — | — | — | — | 170—386% | |
| Current liabilities | 453—1717% | 453+8.4%1717% | 477+12.5%1745% | 542+19.3%2875% | 529+31.1%1595% | 418+9.1%950% | 424+20.8%205% | 455+23.0%881% | 403+24.2%2617% | 383—1821% | 351—1705% | 370—984% | 325—737% | |
| Total liabilities | 453—1717% | 453+8.4%1717% | 477+12.5%1745% | 542+19.3%2875% | 529+31.1%1595% | 418+9.1%950% | 424—205% | 455+23.0%881% | 403+24.2%2617% | 383—1821% | — | 370—984% | 325—737% | |
| Retained earnings | −6,209—−23559% | −6,209—−23559% | −6,227—−22796% | −6,277—−33271% | −6,248—−18849% | −6,124—−13929% | −5,963—−2879% | −5,866—−11362% | −5,837—−37887% | −5,790—−27543% | −5,741—−27899% | −5,691—−15140% | −5,571—−12653% | |
| Shareholders' equity | −426—−1617% | −426—−1617% | −449—−1645% | −524—−2775% | −495—−1495% | −374—−850% | −217—−105% | −403—−781% | −388—−2517% | −362—−1721% | −330—−1605% | −332—−884% | −281—−637% | |
| Total liabilities and equity | 26—100% | 26−40.1%100% | 27−86.8%100% | 19−63.5%100% | 33+115%100% | 44+109%100% | 207+906%100% | 52+37.4%100% | 15−65.0%100% | 21—100% | 21—100% | 38—100% | 44—100% | |
| Shares outstanding | 4.5—— | 4.5+49.1%— | 4.0+44.5%— | 3.4+34.7%— | 3.3+35.1%— | 3.0+37.6%— | 2.8+30.3%— | 2.5+43.0%— | 2.5+87.2%— | 2.2—— | 2.1—— | 1.8—— | 1.3—— | |
| Cash-flow statement | ||||||||||||||
| Share-based compensation | — | — | — | — | 0*—0.0% | 1.9—88.9% | — | — | — | — | — | — | — | |
| Cash from operating activities | −17—−19.6% | −1.7*−103%−7.1% | −0.7*—−2.0% | −12—−76.3% | −3.3*—−22.0% | 62*—2932% | −49*−216%−16.6% | −49—−40508% | −9.2*—−563% | −80*—−3888% | 43*—7701% | −69—−276584% | −36*—— | |
| Cash from investing activities | — | — | — | — | — | — | — | — | 0*—0.0% | — | — | — | — | |
| Cash from financing activities | — | 0*—0.0% | — | — | 0*−100%0.0% | −66*−178%−3128% | 75*—25.4% | 49−28.0%40417% | 2.5*−93.7%152% | 85*—4122% | −41*—−7485% | 67—269260% | 40*—— | |
| Change in cash | −7.0−147%−7.9% | −1.7*—−7.1% | 9.3*−64.0%27.3% | −12—−76.3% | −3.1*—−20.4% | −4.1*−191%−196% | 26*+2058%8.7% | −0.1—−90.8% | −6.7*−269%−411% | 4.6*—222% | 1.2*—217% | −1.8—−7324% | 4.0*—— | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2017. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Events at Glucose Health Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Auditor changed 4 · Change in control 1 · Directors and officers 7 · Material agreement 4 · Agreement ended 1 · Unregistered share sale 1 · Bylaws or fiscal year changed 2
| Filed | What happened | Filing |
|---|---|---|
| Auditor changed | 8-K | |
| Directors and officers | 8-K | |
| Auditor changed | 8-K | |
| Directors and officers | 8-K | |
| Bylaws or fiscal year changed | 8-K | |
| Change in controlDirectors and officersMaterial agreementUnregistered share sale | 8-K/A | |
| Auditor changed | 8-K | |
| Directors and officersMaterial agreement | 8-K | |
| Directors and officers | 8-K | |
| Auditor changed | 8-K | |
| Directors and officers | 8-K | |
| Directors and officersMaterial agreementAgreement endedBylaws or fiscal year changed | 8-K | |
| Material agreement | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Apr 11, 2017
How Glucose Health Inc. compares in Package Foods
- Revenue$0 M · higher than 1% of 253
- Net margin-132.3% · higher than 1% of 247
Peer comparison · Package Foods
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Glucose Health Inc.🇺🇸 | $1 M | — | -132.3% | — |
| Nestlé S.A.🇨🇭 | $256.1 B | 22.4× | 10.1% | +3.8% |
| Danone S.A.🇨🇭 | $50.1 B | 23.2× | 6.7% | -0.8% |
| Ajinomoto Co., Inc.🇯🇵 | $33.5 B | 36.7× | 8.5% | — |
| Foshan Haitian Flavouring and Food Company Ltd.🇨🇳 | $30.5 B | 29.9× | 24.4% | — |
| The Kraft Heinz Company🇺🇸 | $28.3 B | — | -14.0% | -3.5% |
| Nestle India Limited🇮🇳 | $26.9 B | — | — | — |
| Inner Mongolia Yili Industrial Group Co., Ltd.🇨🇳 | $23.9 B | 14.3× | 10.0% | — |
| Yihai Kerry Arawana Holdings Co., Ltd🇨🇳 | $21.0 B | 46.0× | 1.3% | — |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Nestlé S.A.$256.1 B
- Danone S.A.$50.1 B
- Ajinomoto Co., Inc.$33.5 B
- Foshan Haitian Flavouring and Food Company Ltd.$30.5 B
- The Kraft Heinz Company$28.3 B
- Nestle India Limited$26.9 B
Sources and freshness
- Market cap:
- Dec 25, 2022 (last known)
- Annual results:
- For year ending December-2016
- Balance sheet:
- As of December-2016
- Profile updated:
- Nov 16, 2026
Figures from SEC filing, value.today research; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Glucose Health Inc.? Verify and update this profile — free
Show Glucose Health Inc.'s ranking on your website Get the badge
The badge updates itself as the ranking changes.